Implementation of a Structural Mitral Valve Clinic for the Management of Patients With Heart Failure Refractory to Medical Therapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Mitral Regurgitation
- Sponsor
- Queen's University
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Wait time 2
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
This is a prospective Quality Improvement (QI) study using the Model for Improvement framework.
The objective of this study is to implement a structured, comprehensive, innovative, and sustainable approach to the management of patients with advanced mitral valve (MV) disease and heart failure (HF) in Southeastern Ontario and to improve healthcare delivery, patient care, and patient outcomes in the context of structural surgical and percutaneous MV interventions. This will be achieved through the strategic implementation, promotion, and evaluation of:
i.The first local Southeastern Ontario Structural Mitral Valve Clinic using an Interdisciplinary heart team (IHT) at the Kingston Health Sciences Centre (KHSC) and its integration with the KHSC's existing Heart Failure Clinic; ii.The first provincial Structural Mitral Valve Clinic electronic referral service on the Ontario electronic services platform; and iii.The promotion of the above through targeted KT (Knowledge Transfer) outreach activities.
Patients for this study will be recruited through medical referral within the south eastern Ontario, Canada region.
Investigators
Wael Abuzeid
MD, MSc, Interventional Cardiologist, Assistant Professor, Department of Medicine
Queen's University
Eligibility Criteria
Inclusion Criteria
- •All adults (≥18 years of age) patients with primary and secondary moderate to severe MR with HF (preserved or reduced ejection fraction with New York Heart Association (NYHA) Class \>II), who have had at least one previous hospitalization for HR, require specialist advisement, and have provided signed informed consent.
Exclusion Criteria
- •Those who are not eligible for either an MV surgical intervention or a TMVI procedure.
- •Females of childbearing age who are not willing or unable to use a reliable method of birth control.
- •Inpatient referrals.
Outcomes
Primary Outcomes
Wait time 2
Time Frame: At week sixteen following study entry.
The time from acceptance for a procedure to time of pre-procedure imaging.
Wait time 1
Time Frame: At week three following study entry.
The time between date referral made and date acknowledged by cardiologist.
Wait time 3
Time Frame: At week sixteen following study entry.
The time from acceptance for a procedure to time of procedure.
Secondary Outcomes
- Morbidity 2(At one year post procedure.)
- Mortality 1(At 30 days post procedure.)
- Mortality 2(At one year post procedure.)
- Morbidity 1(At 30 days post procedure.)